Drug intelligence / Profile preview

Neuroton

Development stage
Unknown
Lead developer
Amoun Pharmaceutical
Modality
Small Molecules
Administration
Intramuscular, Oral, Buccal
01

Overview

**Neuroton** is a brand name associated with several distinct pharmaceutical and medical products. In clinical research, it most frequently refers to **citicoline** (cytidine-5'-diphosphocholine), a neuroprotective intermediate in the biosynthesis of cell membrane phospholipids. It has been evaluated in randomized clinical trials for its ability to improve retinal function and visual pathway responses in patients with glaucoma and amblyopia. Another widely marketed version of Neuroton (notably by Amoun Pharmaceutical Company) is a **Vitamin B complex** containing Vitamins B1 (thiamine), B6 (pyridoxine), and B12 (cyanocobalamin), which is indicated for the treatment of peripheral neuropathies and nutritional deficiencies. Historically, the name was also applied to **guaifenesin** (guaiacol glyceryl ether) in research regarding its effects on muscle relaxation and animal behavior. Furthermore, the name is used for the **Neuroton-626**, an apparatus designed for the electrodiagnosis of nerve trunk diseases.

Brand names
Neuroton
Other names
CDP-cholinecytidine-5'-diphosphocholineguaiacol glycerine etherguaifenesinVitamin B1+B6+B12
02

Targets

MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)

Beyond the preview

Go deeper on Neuroton.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroton.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call